Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicenter, retrospective analysis
Ontology highlight
ABSTRACT: Anti-programmed death-1 (PD-1) treatment for advanced non-small-cell lung cancer (NSCLC) has improved the survival of patients. However, a significant percentage of patients do not respond. We examined the use of DNA methylation profiles to determine the efficacy of anti-PD-1 treatment in stage IV NSCLC patients.
ORGANISM(S): Homo sapiens
PROVIDER: GSE115246 | GEO | 2021/06/01
REPOSITORIES: GEO
ACCESS DATA